Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008

Journal of Clinical Microbiology

Volumn 50, Issue 8, 2012, Pages 2577-2584

  Du Plessis, Mignon ^a,b,c   Moodley, Chivonne ^a,b,c   Mothibeli, Kedibone M ^a,b,c   Fali, Azola ^a,b,e   Klugman, Keith P ^b,c,d   Von Gottberg, Anne ^a,b,c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d EMORY UNIVERSITY   (United States)

^e NATIONAL RESEARCH FOUNDATION   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PENICILLIN G; RIFAMPICIN;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLONE; GENE SWITCHING; HUMAN; INCIDENCE; INVASIVE MENINGOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SOUTH AFRICA;

CLUSTER ANALYSIS; GENOTYPE; HUMANS; INCIDENCE; MENINGITIS, MENINGOCOCCAL; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS, SEROGROUP B; PENICILLIN RESISTANCE; PREVALENCE; SOUTH AFRICA;

EID: 84864402794     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00401-12     Document Type: Article

References (44)

1. Baker MG, Martin DR, Kieft CE, Lennon D. 2001. A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J. Paediatr. Child Health 37:S13-S19. (Pubitemid 32989606)
2. Bjune G, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
3. Boslego J, et al. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine 13:821-829.
4. Caugant DA, et al. 1986. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Natl. Acad. Sci. U. S. A. 83:4927-4931. (Pubitemid 16075512)
5. Caugant DA, et al. 1987. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol. 169:2781-2792.
6. Caugant DA, et al. 1987. Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis. Infect. Immun. 55:1503-1512. (Pubitemid 17078157)
7. CLSI. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Corless CE, et al. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39: 1553-1558. (Pubitemid 32275465)
9. Coulson GB, et al. 2007. Meningococcal disease in South Africa, 1999-2002. Emerg. Infect. Dis. 13:273-281. (Pubitemid 46193172)
10. Czumbel I. 2011. The epidemiology of invasive meningococcal disease in Europe, 2008-2009, abstr O-01, p 3. Abstr. 11th Eur. Monit. Group Meningococci Meet.
11. Diermayer M, et al. 1999. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 281:1493-1497. (Pubitemid 29200932)
12. Djibo S, et al. 2003. Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Trop. Med. Int. Health 8:1118-1123. (Pubitemid 38008040)
13. Donald PR, Burger PJ, van Zyl LE. 1981. Meningococcal disease at Tygerberg Hospital. S. Afr. Med. J. 60:271-275. (Pubitemid 11051020)
14. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP. 2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46:3208-3214.
15. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530. (Pubitemid 38248742)
16. Finne J, Leinonen M, Makela PH. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357. (Pubitemid 13028927)
17. Gagneux SP, et al. 2002. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J. Infect. Dis. 185:618-626. (Pubitemid 34171466)
18. Gaspar M, Leite F, Brumana L, Felix B, Stella AA. 2001. Epidemiology of meningococcal meningitis in Angola, 1994-2000. Epidemiol. Infect. 127:421-424. (Pubitemid 34097421)
19. Giuliani MM, et al. 2006. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U. S. A. 103:10834-10839. (Pubitemid 44148381)
20. Gray SJ, et al. 2011. The epidemiology and surveillance of meningococcal disease in England and Wales, abstr P-004, p 41. Abstr. 11th Eur. Monit. Group Meningococci Meet.
21. Gray SJ, et al. 2006. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J. Med. Microbiol. 55:887-896. (Pubitemid 43974695)
22. Harrison LH, et al. 2010. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era-United States, 2000-2005. J. Infect. Dis. 201:1208-1224.
23. Huebner RE, Klugman KP, Matai U, Eggers R, Hussey G. 1999. Laboratory surveillance for Haemophilus influenzae type B meningococcal, and pneumococcal disease. Haemophilus Surveillance Working Group. S. Afr. Med. J. 89:924-925. (Pubitemid 29497643)
24. Janda WM, Knapp JS. 2003. Neisseria and Moraxella catarrhalis, p 585-608. In Murray PR, et al (ed), Manual of clinical microbiology, 8th ed, vol 1. ASM Press, Washington, DC.
25. Kustner H. 1979. Meningococcal infection-changing epidemiological patterns in South Africa. Epidemiol. Comments 1979:1-15.
26. Maiden MC, et al. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U. S. A. 95:3140-3145. (Pubitemid 28135868)
27. McGee L, Koornhof HJ, Caugant DA. 1998. Epidemic spread of subgroup III of Neisseria meningitidis serogroup A to South Africa in 1996. Clin. Infect. Dis. 27:1214-1220. (Pubitemid 29242473)
28. Moodley C, et al. 2011. Molecular characterisation of Neisseria meningitidis serogroup B isolates causing invasive disease in South Africa, 2002-2006, abstr P-029, p 95. Abstr. 11th Eur. Monit. Group Meningococci Meet.
29. Murphy E, et al. 2009. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J. Infect. Dis. 200:379-389.
30. Nakhla I, et al. 2005. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Vaccine 23:3288-3293. (Pubitemid 40523122)
31. Oster P, et al. 2007. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. Vaccine 25:3075-3079. (Pubitemid 46482737)
32. Poolman JT, et al. 1986. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet ii:555-558.
33. Potter PC, Donald PR, Moodie J, Slater C, Kibel MA. 1984. Meningitis in Cape Town children. S. Afr. Med. J. 66:759-762. (Pubitemid 15179006)
34. Radstrom P, et al. 1994. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J. Clin. Microbiol. 32:2738-2744. (Pubitemid 24319112)
35. Ryder CS, Beatty DW, Heese HD. 1987. Group B meningococcal infec-tion in children during an epidemic in Cape Town, South Africa. Ann. Trop. Paediatr. 7:47-53. (Pubitemid 17050780)
36. Sacchi CT, et al. 1992. Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J. Clin. Microbiol. 30:1734-1738.
37. Shepard CW, Rosenstein NE, Fischer M. 2003. Neonatal meningococcal disease in the United States, 1990 to 1999. Pediatr. Infect. Dis. J. 22:418-422. (Pubitemid 36578742)
38. Sierra GV, et al. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
39. Sonnenberg P, Silber E, Ho KC, Koornhof HJ. 2000. Meningococcal disease in South African goldmines-epidemiology and strategies for control. S. Afr. Med. J. 90:513-517. (Pubitemid 30386631)
40. Statistics South Africa. 2007. Mid-year population estimates-2007. Statistics South Africa, Pretoria, South Africa. http://www.statssa.gov.za/ publications/P0302/P03022007.pdf.
41. Statistics South Africa. 2008. Mid-year population estimates-2008. Statistics South Africa, Pretoria, South Africa. http://www.statssa.gov.za/ publications/p0302/p03022008.pdf.
42. Taha MK. 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J. Clin. Microbiol. 38:855-857.
43. von Gottberg A, et al. 2008. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin. Infect. Dis. 46:377-386.
44. Zerouali K, Elmdaghri N, Boudouma M, Benbachir M. 2002. Serogroups, serotypes, serosubtypes and antimicrobial susceptibility of Neisseria meningitidis isolates in Casablanca, Morocco. Eur. J. Clin. Microbiol. Infect. Dis. 21:483-485. (Pubitemid 34756928)